Research funding from RR HF for 2008-2010 5 new projects granted support

Two of these are led by researchers employed at the Institute for Cancer Resarch: Gunhild Mælandsmo (photo) and Johanne Olweus.
Funding is distributed to selected high-quality projects by research groups at the Rikshospitalet-Radiumhospitalet. This also includes research units at the University of Oslo when principal investigator (PI) is employed by RR HF.
The following projects were granted support:
Collaborative projects, categori 1 | 2008 | 2009 | 2010 |
Lung cancer - characterization of biological factors for use in diagnosis, prognostication and therapy Project leader: Gunhild Mælandsmo, Dept. of Tumor biology, Institute for cancer research | 100.000 | 900.000 | 900.000 |
The role of monocarboxylate transporters and glutamate signalling in Parkinson's disease Project leader: Vidar Gundersen, The neurology clinic and CMBN. | 100.000 | 900.000 | 900.000 |
Cancer-targeted T cell receptors - the next generation immunotherapeutic drugs Project leader: Johanna Olweus, Dept. of Immunology, Institute for cancer research | 100.000 | 900.000 | 900.000 |
Mechanisms of Cardioprotection in Ischemia and Heart Failure - Role of Myocardial CCN2/Connective Tissue Growth Factor Project leader: HÃ¥vard Attramadal, Institute for surgical research | 100.000 | 900.000 | 900.000 |
An Open Labelled Pilot study to Evaluate the Benefit and Efficacy of Liver Transplantation as Treatment for Selected Patients with Liver Metastases from Colo-Rectal Carcinoma Project leader: Aksel Foss, Surgical clinic | 100.000 | 900.000 | 900.000 |
Sum new fundings: | 500.000 | 4.500.000 | 4.500.000 |